Log In
Print
BCIQ
Print
Print this Print this
 

umeclidinium (GSK573719)

Also known as: 573719

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionLong acting muscarinic acetylcholine antagonist (LAMA)
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

U.S. - Undisclosed Review (Treat chronic obstructive pulmonary disease (COPD));
EU - Standard Review (Treat chronic obstructive pulmonary disease (COPD))

Partner

Vectura Group plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today